Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-20Clinical Trial Update: Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases [Phase 2]
Phase 2 clinical trial evaluating low-dose IL-2 to induce regulatory T cells in various autoimmune and inflammatory diseases; trial complete…
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease [Phase 2]
Phase 2 open-label safety and tolerability study of AIN457 in moderate to severe Crohn's disease was terminated; results were posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation [Phase 2]
Phase 2 trial assessing the efficacy and safety of oral OPS-2071 in Crohn's disease with active inflammation; study terminated with results …
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease [Phase 3]
Phase 3 trial evaluating vedolizumab in biologic-naïve Korean patients with moderate to severe inflammatory bowel disease (Crohn's disease a…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Dietary Treatment of Crohn's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dietary treatment for Crohn's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: A Trial of Yoga in Pediatric Inflammatory Bowel Disease [NA]
A completed clinical trial investigated yoga as an intervention for pediatric inflammatory bowel disease; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease [Phase 2]
A Phase 2 clinical trial evaluating ALX-0600 for safety and efficacy in active Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab [Phase 3]
A Phase 3 trial comparing treat-to-target maintenance strategies versus routine care in Crohn's disease patients treated with ustekinumab ha…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores [Phase 2]
Phase 2 trial evaluating 5-HTP in patients with inflammatory bowel disease in clinical and biologic remission to assess effects on fatigue s…
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 [Phase 2]
Phase 2 trial update on ALX-0600 for Crohn's disease completed; safety and efficacy data reported.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306) [Phase 3]
Phase 3 trial for ontamalimab as induction therapy in moderate to severe Crohn's disease; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305) [Phase 3]
Phase 3 trial of ontamalimab as induction therapy for moderate-to-severe Crohn's disease terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the antibody GSK1070806 for moderate to severe Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease [Phase 2, Phase 3]
Phase 2/3 trial of OPC-6535 in active Crohn's disease completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) [Phase 4]
A Phase 4 study sponsored by Janssen banked samples from Crohn's disease and ulcerative colitis patients to identify biomarkers that may pre…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
Observational real-world study of Inflectra in inflammatory bowel disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease [Phase 3]
Phase 3 open-label trial assessing efficacy and safety of Anti-MAP therapy in adults with Crohn's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease [Phase 3]
Phase 3 trial evaluating two regimens for moderate to severe Crohn's disease has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) [Phase 4]
Phase 4 trial comparing intraoperative TAP block with bupivacaine/dexamethasone to liposomal bupivacaine (Exparel) for postoperative pain; s…
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease [Phase 2]
Phase 2 dose-finding trial for OPC-6535 in active Crohn's disease was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease [Phase 2]
Phase 2 trial updating on gut microbiota modification for refractory Crohn's disease; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Fecal Microbiota Transplantation in Pediatric Patients [Phase 1]
Phase 1 clinical trial evaluating fecal microbiota transplantation in pediatric patients with inflammatory bowel diseases, completed with re…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates [Phase 3]
Phase 3 trial investigating the use of indocyanine green to reduce anastomotic leakage in colorectal surgery for colorectal cancer and Crohn…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. [Phase 4]
Phase 4 trial comparing loss of response between an adalimumab biosimilar and the original adalimumab in Crohn's disease and ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: ASTIC Autologous Stem Cell Transplantation for Crohn's Disease [Phase 3]
Phase 3 trial of ASTIC autologous stem cell transplantation for Crohn's disease was terminated.